PortfoliosLab logo

AbCellera Biologics Inc. (ABCL)

Equity · Currency in USD · Last updated Dec 8, 2022

Company Info

ISINCA00288U1066
CUSIP00288U106
SectorHealthcare
IndustryBiotechnology

Trading Data

Previous Close$11.14
Year Range$5.72 - $15.74
EMA (50)$12.17
EMA (200)$11.16
Average Volume$2.00M
Market Capitalization$3.19B

ABCLShare Price Chart


Loading data...

ABCLPerformance

The chart shows the growth of $10,000 invested in AbCellera Biologics Inc. in Dec 2020 and compares it to the S&P 500 index or another benchmark. It would be worth nearly $1,891 for a total return of roughly -81.09%. All prices are adjusted for splits and dividends.


0.00%20.00%40.00%60.00%80.00%JulyAugustSeptemberOctoberNovemberDecember
33.55%
0.85%
ABCL (AbCellera Biologics Inc.)
Benchmark (^GSPC)

ABCLCompare to other instruments

Search for stocks, ETFs, and funds to compare with ABCL

ABCLReturns in periods

Returns over 1 year are annualized

PeriodReturnBenchmark
1M-6.47%4.33%
6M42.27%-5.45%
YTD-22.10%-17.46%
1Y-17.48%-14.32%
5Y-56.80%3.66%
10Y-56.80%3.66%

ABCLMonthly Returns Heatmap


JanFebMarAprMayJunJulAugSepOctNovDec
2022-37.13%-3.11%11.94%-21.33%-0.65%39.76%-5.73%6.37%-7.40%19.62%8.79%-13.44%
202131.29%-28.62%-9.94%-21.53%0.68%-18.00%-31.05%10.61%19.43%-21.61%-4.77%-4.41%
2020-31.68%

ABCLSharpe Ratio Chart

The Sharpe ratio shows whether the portfolio's excess returns are due to smart investment decisions or a result of taking a higher risk. The higher a portfolio's Sharpe ratio, the better its risk-adjusted performance.

The current AbCellera Biologics Inc. Sharpe ratio is -0.34. A negative Sharpe ratio means that the risk-free rate is higher than the portfolio's return. This value does not convey any meaningful information.

The chart below displays rolling 12-month Sharpe Ratio.


-1.00-0.80-0.60-0.40-0.200.00JulyAugustSeptemberOctoberNovemberDecember
-0.34
-0.67
ABCL (AbCellera Biologics Inc.)
Benchmark (^GSPC)

ABCLDividend History


AbCellera Biologics Inc. doesn't pay dividends

ABCLDrawdowns Chart

The Drawdowns chart displays portfolio losses from any high point along the way.


-100.00%-80.00%-60.00%-40.00%-20.00%0.00%2022FebruaryMarchAprilMayJuneJulyAugustSeptemberOctoberNovemberDecember
-81.09%
-17.98%
ABCL (AbCellera Biologics Inc.)
Benchmark (^GSPC)

ABCLWorst Drawdowns

The table below shows the maximum drawdowns of the AbCellera Biologics Inc.. A maximum drawdown is an indicator of risk. It shows a reduction in portfolio value from its maximum due to a series of losing trades.

The maximum drawdown since January 2010 for the AbCellera Biologics Inc. is 90.29%, recorded on May 11, 2022. The portfolio has not recovered from it yet.


Depth

Start

To Bottom

Bottom

To Recover

End

Total

-90.29%Dec 14, 2020355May 11, 2022

ABCLVolatility Chart

Current AbCellera Biologics Inc. volatility is 41.19%. The chart below shows the rolling 10-day volatility. Volatility is a statistical measure showing how big price swings are in either direction. The higher asset volatility, the riskier it is, because the price movements are less predictable.


20.00%40.00%60.00%80.00%100.00%120.00%JulyAugustSeptemberOctoberNovemberDecember
41.19%
22.83%
ABCL (AbCellera Biologics Inc.)
Benchmark (^GSPC)